Immediate Impact
1 by Nobel laureates 2 from Science/Nature 56 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
2024 Standout
Works of Jun Kawashima being referenced
Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jun Kawashima | 32 | 133 | 25 | 62 | 47 | 17 | 198 | |
| Sylvain Lamure | 13 | 82 | 42 | 40 | 9 | 16 | 201 | |
| Remus Vezan | 29 | 157 | 29 | 92 | 41 | 16 | 229 | |
| Patricia Steinert | 21 | 173 | 85 | 48 | 43 | 19 | 243 | |
| Ana Alarcón Tomás | 9 | 160 | 33 | 48 | 38 | 22 | 212 | |
| Valentín Ortiz‐Maldonado | 31 | 94 | 14 | 36 | 22 | 20 | 137 | |
| Sandra B. Horowitz | 20 | 218 | 71 | 76 | 38 | 14 | 294 | |
| Erin Mullane | 20 | 262 | 14 | 48 | 70 | 15 | 287 | |
| Caroline Besley | 19 | 102 | 12 | 26 | 19 | 15 | 136 | |
| Miriam Sánchez‐Escamilla | 11 | 184 | 35 | 55 | 70 | 13 | 229 | |
| Vicky Wu | 19 | 162 | 20 | 25 | 26 | 24 | 210 |
All Works
Login with ORCID to disown or claim papers
Loading papers...